Question 1

What is the catalog number for 3- (2,2-dimethylhydrazino) -4-ethoxycyclobut-3-ene-1,2-dione?

Accepted Answer

The catalog number for 3- (2,2-dimethylhydrazino) -4-ethoxycyclobut-3-ene-1,2-dione is OR26834.

Question 2

What sizes are available for 3- (2,2-dimethylhydrazino) -4-ethoxycyclobut-3-ene-1,2-dione?

Accepted Answer

3- (2,2-dimethylhydrazino) -4-ethoxycyclobut-3-ene-1,2-dione is available in the following size(s): 1 Each.

Question 3

Is 3- (2,2-dimethylhydrazino) -4-ethoxycyclobut-3-ene-1,2-dione in stock?

Accepted Answer

3- (2,2-dimethylhydrazino) -4-ethoxycyclobut-3-ene-1,2-dione is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 5

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

Question 6

Do you ship this product with dry ice?

Accepted Answer

Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.

3- (2,2-dimethylhydrazino) -4-ethoxycyclobut-3-ene-1,2-dione

Product Specifications

CAS Number

MDL Number

Purity

Smiles

Frequently Asked Questions

Explore Other Products

H1N1 TaqMan RT-PCR Kit

MSH6 (DNA Mismatch Repair Protein) (MSH6/3091), CF568 conjugate, 0.1mg/mL

Anti-MCP4/CCL13 Antibody Picoband®, Dylight550 Conjugate

Rat NGF/NGF Beta ELISA Kit PicoKine®, Carrier-free

TPO (Thyroid Peroxidase) (Thyroid Marker) (TPO/1921), CF594 conjugate, 0.1mg/mL

ICOS-L / ICOS Ligand / B7RP-1 (Immuno-Oncology Target) (ICOSL/3260), 0.2mg/mL